Tumorigenicity of the miR-17-92 cluster distilled: Figure 1.
Open Access
- 1 January 2010
- journal article
- editorial
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (1) , 1-4
Abstract
The miR-17-92 gene cluster, with its six different mature microRNAs (miRNAs), has an established oncogenic function. However, the oncogenic contribution of each individual miRNA in the cluster has not been assigned. Two studies published in the December 15, 2009, issue of Genes & Development by Mu and colleagues (pp. 2806–2811) and Olive and colleagues (pp. 2839–2849) dissected the miR-17-92 cluster to its individual miRNA components and identified their relative contributions to oncogenic transformation in mouse model systems.Keywords
This publication has 35 references indexed in Scilit:
- miR-19 is a key oncogenic component of mir-17-92Genes & Development, 2009
- A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell ProliferationCancer Research, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Identification and Characterization of a Novel Gene, C13orf25 , as a Target for 13q31-q32 Amplification in Malignant LymphomaCancer Research, 2004
- Bim is a suppressor of Myc-induced mouse B cell leukemiaProceedings of the National Academy of Sciences, 2004
- Prediction of Mammalian MicroRNA TargetsCell, 2003
- An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivoNature Genetics, 2003
- A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer TherapyCell, 2002
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985